LLY: Legal Battle Over FDA's Decision on Eli Lilly's Weight Loss Drug

The Outsourcing Facilities Association, representing companies producing generic versions of Eli Lilly's (LLY, Financial) weight loss drug, has filed a lawsuit against the U.S. Food and Drug Administration (FDA) in a Texas federal court. The group claims that the FDA's decision to remove Eli Lilly's drug from the shortage list was "arbitrary, capricious, and unlawful." This decision, they argue, limits patient access to crucial medications, prompting a request for the court to overturn or modify the FDA's r ...